ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,947.89
0.15%
S&P 500
5,650.39
0.34%
Dow Jones
40,712.52
1.25%
US Dollar vs Yen
158.568
0.27%
Brent Oil
83.37
-1.15%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. CytomX Therapeutics Inc (CTMX)

  7. CytomX Therapeutics Inc (CTMX) ニュース

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CTMX
日付受信時刻ニュースソース見出しコード企業名
2016/11/1006 : 06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/11/1006 : 06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/11/1006 : 05GlobeNewswire Inc.CytomX to Present at the Jefferies 2016 London Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
2016/11/0406 : 02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CTMXCytomX Therapeutics Inc
2016/11/0405 : 43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTMXCytomX Therapeutics Inc
2016/11/0405 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
2016/11/0405 : 05GlobeNewswire Inc.CytomX Therapeutics Announces Third Quarter 2016 Financial Results and Provides Pipeline UpdateNASDAQ:CTMXCytomX Therapeutics Inc
2016/10/2721 : 00GlobeNewswire Inc.CytomX Therapeutics to Announce Third Quarter 2016 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
2016/10/1304 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/10/0605 : 37Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CTMXCytomX Therapeutics Inc
2016/10/0403 : 33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/09/2908 : 15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/09/2908 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/08/1201 : 30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/08/0405 : 24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTMXCytomX Therapeutics Inc
2016/08/0405 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
2016/08/0405 : 01GlobeNewswire Inc.CytomX Announces Second Quarter 2016 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
2016/07/2805 : 30GlobeNewswire Inc.CytomX Therapeutics to Announce Second Quarter 2016 Financial Results and Provide Mid-Year UpdateNASDAQ:CTMXCytomX Therapeutics Inc
2016/06/2207 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1505 : 30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1505 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1505 : 09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1505 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1505 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1505 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1405 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1405 : 03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1321 : 00GlobeNewswire Inc.CytomX Therapeutics Appoints John A. Scarlett, M.D., to Board of DirectorsNASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1107 : 22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2016/06/1105 : 14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTMX

最近閲覧した銘柄

BIT
EUDV
Ssga Spdr S&p Euro Divid...
USOTC
CVTNF
Civtanavi Systems (GM)
BIT
NSCIT5410CA9
Italy
BIT
P20VW1
NLBNPIT20VW1 20241220 38
BIT
FDIVER
Vontobel Financial Produ...
BIT
P1V9Q3
NLBNPIT1V9Q3 20991231 14...
BIT
P1WLN5
NLBNPIT1WLN5 20991231 52...
BIT
P1V8J0
NLBNPIT1V8J0 20241220 42...
BIT
P1YKP8
NLBNPIT1YKP8 20991231 30...
BIT
F37996
Vontobel Financial Produ...
BIT
P1XY13
NLBNPIT1XY13 20991231 85...
BIT
DES2
L&G DAX Daily 2x Short U...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有